Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
对既往接受过奥希替尼治疗的 EGFR 突变型非小细胞肺癌患者再次使用阿法替尼:一项多中心 II 期试验方案(REAL 研究)
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-23-12
Araki, Taisuke; Kanda, Shintaro; Komatsu, Masamichi; Sonehara, Kei; Tateishi, Kazunari; Takada, Munetake; Kato, Akane; Yamamoto, Manabu; Nishie, Kenichi; Hama, Mineyuki; Agatsuma, Toshihiko; Kakizaki, Yumiko; Yoshiike, Fumiaki; Matsuo, Akemi; Chiaki, Tomoshige; Samizo, Kanae; Takagi, Yoshiko; Yamaura, Maki; Hanaoka, Masayuki; Koizumi, Tomonobu